Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Lung India ; 41(1): 55-59, 2024 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-38160460

RESUMO

Antiviral combinations have been proposed as treatment for influenza in order to increase the antiviral activity by action at different sites of action as well as obviate the emergence of drug resistance to the commonly used antiviral agents like oseltamivir. Nitazoxanide has been found to exhibit anti-influenza viral activity with clinical benefit in a previous study. We recruited 242 cases of SARI, among whon 67 were confirmed to have influenza viral infection. In a randomized blinded fashion, 34 patients received a combination of nitazoxanide and oseltamivir whereas 33 cases received oseltamivir alone. Clinical parameters were followed in both groups and the nasal swabs were re-tested on day 6 for influenza positivity and the cycle threshold (CT) values. No significant differences were observed in terms of time for resolution of fever, other symptoms, and SOFA scores. Nine patients succumbed during the course of the illness that included three in the oseltamivir group and six in the combination group. All but one of those who expired had an underlying co-morbid illness. Our preliminary data suggest that the addition of nitazoxanide does not improve outcomes in hospitalized patients with influenza. Larger studies are recommended for statistically robust conclusions.

2.
Ann Clin Microbiol Antimicrob ; 22(1): 55, 2023 Jul 05.
Artigo em Inglês | MEDLINE | ID: mdl-37408075

RESUMO

Infections in critically-ill patients caused by extensively-drug-resistant (XDR)-Pseudomonas aeruginosa are challenging to manage due to paucity of effective treatment options. Cefepime/zidebactam, which is currently in global Phase 3 clinical development (Clinical Trials Identifier: NCT04979806, registered on July 28, 2021) is a novel mechanism of action based ß-lactam/ ß-lactam-enhancer combination with a promising activity against a broad-range of Gram-negative pathogens including XDR P. aeruginosa. We present a case report of an intra-abdominal infection-induced sepsis patient infected with XDR P. aeruginosa and successfully treated with cefepime/zidebactam under compassionate use. The 50 year old female patient with past-history of bariatric surgery and recent elective abdominoplasty and liposuction developed secondary pneumonia and failed a prolonged course of polymyxins. The organism repeatedly isolated from the patient was a New-Delhi metallo ß-lactamase-producing XDR P. aeruginosa resistant to ceftazidime/avibactam, imipenem/relebactam and ceftolozane/tazobactam, susceptible only to cefepime/zidebactam. As polymyxins failed to rescue the patient, cefepime/zidebactam was administered under compassionate grounds leading to discharge of patient in stable condition. The present case highlights the prevailing precarious scenario of antimicrobial resistance and the need for novel antibiotics to tackle infections caused by XDR phenotype pathogens.


Assuntos
Infecções Intra-Abdominais , Infecções por Pseudomonas , Sepse , Humanos , Cefepima/uso terapêutico , Cefepima/farmacologia , Infecções por Pseudomonas/tratamento farmacológico , Ensaios de Uso Compassivo , Cefalosporinas/uso terapêutico , Cefalosporinas/farmacologia , Antibacterianos/uso terapêutico , Antibacterianos/farmacologia , Monobactamas/farmacologia , Pseudomonas aeruginosa , beta-Lactamases/genética , Sepse/tratamento farmacológico , Infecções Intra-Abdominais/tratamento farmacológico , Polimixinas , Testes de Sensibilidade Microbiana
3.
Lung India ; 32(3): 220-4, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25983406

RESUMO

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by an interaction of various environmental influences especially cigarette smoking and genetic determinants. The prevalence of this disease is ever increasing and characterization of the genetic determinants of the disease has been undertaken globally. The 'A disintegrin and metalloprotease 33' (ADAM 33) gene is one candidate gene that has been studied. OBJECTIVE: Our objective was to investigate whether single nucleotide polymorphisms in ADAM33 gene are associated with COPD in long-term tobacco smokers in the ethnic Kashmiri population of northern India. MATERIALS AND METHODS: This was a randomized case-control study, which included 78 stable COPD (GOLD stage11-IV) patients, who were compared with 77 age- and sex-matched long-term tobacco smokers (>20 pack years) without any evidence of COPD. Polymorphic analysis for three single nucleotide polymorphisms (SNPs), (T1, T2, and Q1) of the ADAM33 gene was done by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) followed by sequencing. The data were analyzed by descriptive statistics and comparative evaluation was done by parametric/non-parametric tests. RESULTS: The analysis of the T1, T2, and Q1 SNPs, revealed that the frequencies of the T2GG, T1GG, and the Q1AG genotypes were significantly higher in patients with COPD in comparison with the controls (P < 0.001). Similarly, the T1G and T2G allele frequency was higher in the patients than in the controls (p = 0.177 and 0.43, respectively). CONCLUSION: Three SNPs of the ADAM33 gene were significantly associated with COPD in the Kashmiri population of India. This study establishes the possible role of ADAM33 SNPS in the causation of COPD. Further studies across different geographical areas in the country will unravel the contribution of this gene in the causation of COPD in India.

4.
J Public Health Policy ; 35(4): 499-505, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24831677

RESUMO

Pepper gas is used for riot control in many parts of the world. Yet, its effects on bystanders are largely unreported. We fielded a questionnaire-based survey of 500 bystanders exposed to gas when police used pepper grenades against belligerent 'stone-pelters' in the northern Indian state of Jammu & Kashmir. Of 294 non-combatants who consented to participate in our survey, 97 per cent developed cough and irritation of the throat within few seconds of breathing the pungent smelling gas. They reported respiratory problems, dermatologic symptoms, sleep disturbances, and mood changes with varying frequency. Sixteen reported exacerbations of underlying respiratory disorders, with one temporally related to death. Symptoms led 51 to get medical attention. Nearly all respondents reported that symptoms recurred on re-exposure. We conclude that use of pepper grenades can cause serious acute symptoms in non-combatants accidentally exposed. We recommend alternate methods of riot control - water cannons, baton charges, tasers, plastic or rubber bullets, and so on - that have no collateral side effects on non-combatants be considered for routine use.


Assuntos
Exposição por Inalação/efeitos adversos , Extratos Vegetais/efeitos adversos , Gases Lacrimogênios/efeitos adversos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Tosse/induzido quimicamente , Feminino , Humanos , Índia , Lactente , Masculino , Pessoa de Meia-Idade , Polícia , Adulto Jovem
5.
Int J Mycobacteriol ; 3(2): 155-7, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26786339

RESUMO

A 16-year-old female presented with a 6-month history of a gradually increasing swelling of the left side of her face. A panoramic radiographic view of the mandible showed diffuse radiolucency in the ramus of the mandible with a loss of cortication on the superior and anterior portion of the condyle. The computed tomography (CT) scan revealed destruction of the mandibular bone and a large retromandibular and inferior temporal fossa mass with areas of breakdown. The biopsy was consistent with tubercular osteomyelitis. Antitubercular therapy resulted in a marked reduction of the size of the swelling over a 9-month period.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...